文献

J-GLOBAL ID：201402201376412382   整理番号：14A0294078

去勢抵抗性前立腺癌の患者におけるアンドロゲン受容体mRNAのエクソン4に結合した核酸アンチセンスオリゴヌクレオチドであるEZN-4176のヒト初回投与第I相試験(First-in-human Phase I study)

First-in-human Phase I study of EZN-4176, a locked nucleic acid antisense oligonucleotide to exon 4 of the androgen receptor mRNA in patients with castration-resistant prostate cancer

著者 (36件)： BIANCHINI D (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  BIANCHINI D (Center for Prostate and Urologic Cancers, NY, USA) ,  OMLIN A (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  OMLIN A (Center for Prostate and Urologic Cancers, NY, USA) ,  PEZARO C (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  PEZARO C (Center for Prostate and Urologic Cancers, NY, USA) ,  LORENTE D (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  LORENTE D (Center for Prostate and Urologic Cancers, NY, USA) ,  FERRALDESCHI R (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  FERRALDESCHI R (Center for Prostate and Urologic Cancers, NY, USA) ,  MUKHERJI D (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  MUKHERJI D (Center for Prostate and Urologic Cancers, NY, USA) ,  CRESPO M (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  CRESPO M (Center for Prostate and Urologic Cancers, NY, USA) ,  FIGUEIREDO I (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  FIGUEIREDO I (Center for Prostate and Urologic Cancers, NY, USA) ,  MIRANDA S (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  MIRANDA S (Center for Prostate and Urologic Cancers, NY, USA) ,  RIISNAES R (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  RIISNAES R (Center for Prostate and Urologic Cancers, NY, USA) ,  ZIVI A (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  ZIVI A (Center for Prostate and Urologic Cancers, NY, USA) ,  BUCHBINDER A (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  BUCHBINDER A (Center for Prostate and Urologic Cancers, NY, USA) ,  RATHKOPF D E (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  RATHKOPF D E (Center for Prostate and Urologic Cancers, NY, USA) ,  ATTARD G (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  ATTARD G (Center for Prostate and Urologic Cancers, NY, USA) ,  SCHER H I (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  SCHER H I (Center for Prostate and Urologic Cancers, NY, USA) ,  BONO J de (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  BONO J de (Center for Prostate and Urologic Cancers, NY, USA) ,  BONO J de (ENZON Pharmaceuticals Inc., Bridgewater, NJ, USA) ,  DANILA D C (Royal Marsden NHS Foundation Trust and The Inst. of Cancer Res., Surrey, GBR) ,  DANILA D C (Center for Prostate and Urologic Cancers, NY, USA) ,  DANILA D C (ENZON Pharmaceuticals Inc., Bridgewater, NJ, USA)
資料名： British Journal of Cancer  (British Journal of Cancer)
巻： 109  号： 10  ページ： 2579-2586  発行年： 2013年11月12日 
JST資料番号： C0922B  ISSN： 0007-0920  資料種別： 逐次刊行物 (A)
発行国： イギリス (GBR)  言語： 英語 (EN)

タイトルに関連する用語 (10件)： 去勢抵抗性前立腺癌 ,  患者 ,  アンドロゲン受容体 ,  mRNA ,  エクソン ,  核酸 ,  アンチセンスオリゴヌクレオチド ,  ヒト ,  投与 ,  第I相試験